News
A surging interest in Medicare Advantage among the retirement-aged population and the fast-consolidating ranks of private payers has some experts asking whether the program might be the future of Medicare overall.
Florida Hospital has seen significant improvements in its case mix index, resulting in a $72.5 million increase in appropriate reimbursement since the implementation of a clinical documentation improvement program.
Aetna expects its proposed $37 billion acquisition of Humana to close during the second half of 2016, Chairman and CEO Mark Bertolini said during an investor call Thursday while commenting on the insurer's first quarter financial results.
Physician payments rates are on the rise across the United States, according to a national compensation survey released Friday from MD Ranger.
Currently, doctors are paid for things such as tests, treatments and other procedures, but not necessarily for spending time with patients to learn more about their health or develop a treatment plan. Officials say the new payment program will change that.
Administration officials moved Thursday to improve low Medicaid enrollment for emerging prisoners, urging states to start signups before release and expand eligibility to thousands of former inmates in halfway houses near the end of their sentences.
The criticism of the drug company's price increases are valid, said new board member William Ackman.
The California Medical Association is opting in to a legal battle currently being waged by the ACLU of Northern California against Dignity Health, one of the largest health systems in the country.
The report is intended to reveal multiple inefficiencies in how large U.S. businesses manage their expenses.
The Centers for Medicare and Medicaid Services has made public a "lightly redacted" copy of the letter it sent to beleaguered blood-testing company Theranos on March 18, with newly revealed allegations that its proprietary testing devices often failed to meet the company's own accuracy requirements for certain tests -- in one instance, failing to accurately detect prostate cancer.